
RTP oncology firm G1 strikes 3rd licensing deal in 3 months, latest one being worth up to $170M
Date Published:
RESEARCH TRIANGLE PARK – G1 Therapeutics has struck another development deal for its oncology portfolio, the latest one announced Monday…